These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2278115)

  • 41. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
    Lin JS; Chang WC; Lui SM
    Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 44. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH
    Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experience with chemical prosthesis in impotence: report of 138 cases].
    Wang ZR
    Zhonghua Wai Ke Za Zhi; 1988 Apr; 26(4):203-5, 253. PubMed ID: 2461844
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J; Postma HJ; Steffens L
    Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of male impotence--a pharmacologic erection program.
    Sanfelippo CJ; Deason AM; Tully AJ; Dennis RL; Leitner WA; Spivey C; Morgan C; Holmes B; Russell RT
    Ala Med; 1988 May; 57(11):17-9. PubMed ID: 3389297
    [No Abstract]   [Full Text] [Related]  

  • 48. [2 years' experiences with cavernosal autoinjection therapy].
    Stief CG; Thon WF; Scherb W; Gall H; Bähren W
    Urologe A; 1987 Sep; 26(5):294-6. PubMed ID: 2446413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks of self-injection therapy for impotence.
    Millard RJ; Stricker PD; Lynch WJ; Dean TE; Murnaghan GF; Breslin FH
    Med J Aust; 1996 Jul; 165(2):117-8. PubMed ID: 8692055
    [No Abstract]   [Full Text] [Related]  

  • 50. [Corpus cavernosum autoinjection therapy: initial experiences in erectile dysfunction].
    Stief CG; Bähren W; Gall H; Scherb W; Gallwitz A; Altwein JE
    Urologe A; 1986 Jan; 25(1):63-6. PubMed ID: 2421473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacologic injection therapy.
    Zorgniotti AW
    Semin Urol; 1986 Nov; 4(4):233-5. PubMed ID: 3797892
    [No Abstract]   [Full Text] [Related]  

  • 52. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 53. Prolonged erections following intracorporeal injection of medications to overcome impotence.
    Watters GR; Keogh EJ; Carati CJ; Earle CM; Wisniewski ZS; Tulloch AG; Lord DJ
    Br J Urol; 1988 Aug; 62(2):173-5. PubMed ID: 3408889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracavernous papaverine for impotence in spinal cord injured patients.
    Kapoor VK; Chahal AS; Jyoti SP; Mundkur YJ; Kotwal SV; Mehta VK
    Paraplegia; 1993 Oct; 31(10):675-7. PubMed ID: 8259331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
    Viswaroop B; B A; Gopalakrishnan G
    Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intracavernous infusion of drugs].
    Bellorofonte C; Dell'Acqua S; Ruoppolo M; Zaatar C; Tombolini P
    Arch Ital Urol Nefrol Androl; 1992 Sep; 64(3):251-4. PubMed ID: 1439852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Priapism as a complication of the treatment of impotence by local injections of papaverine].
    Kaczmarek A
    Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.